Related references
Note: Only part of the references are listed.Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer's Disease: Systematic Review and Meta-Analysis
Marco Zuin et al.
DIAGNOSTICS (2021)
Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease
Yueming Hu et al.
JOURNAL OF LIPID RESEARCH (2021)
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice
Julie C. Ullman et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
Jerome Robert et al.
MOLECULAR NEURODEGENERATION (2020)
High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma
Suresh K. Swaminathan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes
Joel W. Blanchard et al.
NATURE MEDICINE (2020)
Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy
Yutong Zhou et al.
SCIENCE ADVANCES (2020)
Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis
Andrew L. Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Knockout of apolipoprotein A-I decreases parenchymal and vascular β-amyloid pathology in the Tg2576 mouse model of Alzheimer's disease
L. Contu et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro
Roberta Dal Magro et al.
FRONTIERS IN NEUROSCIENCE (2019)
Targeting the transferrin receptor for brain drug delivery
Kasper Bendix Johnsen et al.
PROGRESS IN NEUROBIOLOGY (2019)
Development, synthesis, and 68Ga-Labeling of a Lipophilic complexing agent for atherosclerosis PET imaging
Jennyfer Yong-Sang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles
Bruna dos Santos Rodrigues et al.
PHARMACEUTICAL RESEARCH (2019)
ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes
Varun Rawat et al.
JOURNAL OF NEUROSCIENCE (2019)
Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
Fan Liao et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis
Philip L. S. M. Gordts et al.
MATRIX BIOLOGY (2018)
The shape effect of reconstituted high-density lipoprotein nanocarriers on brain delivery and Aβ clearance
Huahua Song et al.
NANO RESEARCH (2018)
Artificial apolipoprotein corona enables nanoparticle brain targeting
Roberta Dal Magro et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry
Zsuzsanna Kuklenyik et al.
PLOS ONE (2018)
Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery
Lin Cui et al.
DRUG DELIVERY (2018)
Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women
Kristyn A. Bates et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high density lipoproteins in bioengineered human vessels
Jerome Robert et al.
ELIFE (2017)
SR-BI Mediated Transcytosis of HDL in Brain Microvascular Endothelial Cells Is Independent of Caveolin, Clathrin, and PDZK1
Karen Y. Fung et al.
FRONTIERS IN PHYSIOLOGY (2017)
Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis
Sofia Fernandez-De-Retana et al.
SCIENTIFIC REPORTS (2017)
HDL mimetic CER-001 targets atherosclerotic plaques in patients
Kang He Zheng et al.
ATHEROSCLEROSIS (2016)
Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier
Nathalie Strazielle et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
Cristina Merino-Zamorano et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies
Anat Boehm-Cagan et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes
Kasper Bendix Johnsen et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery
Qingxiang Song et al.
MOLECULAR PHARMACEUTICS (2016)
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models
Carlos Perez-Medina et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Refined purification strategy for reliable proteomic profiling of HDL2/3: Impact on proteomic complexity
Michael Holzer et al.
Scientific Reports (2016)
Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids
Pedro Ramos-Cabrer et al.
ACS OMEGA (2016)
ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease
Hussein N. Yassine et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Apolipoprotein A-I: A Molecule of Diverse Function
Manaswini Mangaraj et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2016)
Nanodiscs as a Modular Platform for Multimodal MR-Optical Imaging
Christiane E. Carney et al.
BIOCONJUGATE CHEMISTRY (2015)
Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core
Andrew J. Clark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A europium-lipoprotein nanocomposite for highly-sensitive MR-fluorescence multimodal imaging
Qi Wang et al.
RSC ADVANCES (2015)
Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease
Ajay Gupta et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles
Zu T. Shen et al.
PLOS ONE (2015)
Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer's Disease by Accelerating the Clearance of Amyloid-Beta
Qingxiang Song et al.
ACS NANO (2014)
A pyrene based fluorescence approach to study conformation of apolipoprotein E3 in macrophage-generated nascent high density lipoprotein
Sea H. Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
HDL and cholesterol handling in the brain
Cecilia Vitali et al.
CARDIOVASCULAR RESEARCH (2014)
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer's Disease
Sophie Stukas et al.
CELL METABOLISM (2014)
Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages
Alexander B. Sigalov
CONTRAST MEDIA & MOLECULAR IMAGING (2014)
Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins
Anne von Zychlinski et al.
JOURNAL OF PROTEOMICS (2014)
Identification of a unique TGF-β dependent molecular and functional signature in microglia
Oleg Butovsky et al.
NATURE NEUROSCIENCE (2014)
Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner
Lance A. Johnson et al.
NEUROBIOLOGY OF DISEASE (2014)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice
Lihong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
What are lipoproteins doing in the brian?
Hong Wang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Intravenously Injected Human Apolipoprotein A-I Rapidly Enters the Central Nervous System via the Choroid Plexus
Sophie Stukas et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
Bruce Reed et al.
JAMA NEUROLOGY (2014)
EPR assessment of protein sites for incorporation of Gd(III) MRI contrast labels
Jens O. Lagerstedt et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2013)
Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
Devin T. Wiley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
Philip B. Verghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Collagen-Specific Peptide Conjugated HDL Nanoparticles as MRI Contrast Agent to Evaluate Compositional Changes in Atherosclerotic Plaque Regression
Wei Chen et al.
JACC-CARDIOVASCULAR IMAGING (2013)
Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice
Min Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)
Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation
Eiron Cudaback et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Abca1 Deficiency Affects Alzheimer's Disease-Like Phenotype in Human ApoE4 But Not in ApoE3-Targeted Replacement Mice
Nicholas F. Fitz et al.
JOURNAL OF NEUROSCIENCE (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell et al.
NATURE (2012)
Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology
Robert W. Mahley et al.
NEURON (2012)
LRP1 expression in cerebral cortex, choroid plexus and meningeal blood vessels: Relationship to cerebral amyloid angiopathy and APOE status
Wan Adriyani W. Ruzali et al.
NEUROSCIENCE LETTERS (2012)
Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review
Helena C. Chui et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice
Iliya Lefterov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
Terry L. Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Proteomic Characterization of Human Plasma High Density Lipoprotein Fractionated by Gel Filtration Chromatography
Scott M. Gordon et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhihong Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters Relevance to Antioxidative Function
W. Sean Davidson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Comparison of Synthetic High Density Lipoprotein (HDL) Contrast Agents for MR Imaging of Atherosclerosis
David P. Cormode et al.
BIOCONJUGATE CHEMISTRY (2009)
High-Density Lipoprotein Transport Through Aortic Endothelial Cells Involves Scavenger Receptor BI and ATP-Binding Cassette Transporter G1
Lucia Rohrer et al.
CIRCULATION RESEARCH (2009)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Human apolipoprotein A-I binds amyloid-β and prevents Aβ-induced neurotoxicity
Andrea C. Paula-Lima et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex
Woojin S. Kim et al.
JOURNAL OF NEUROCHEMISTRY (2009)
High-Relaxivity Gadolinium-Modified High-Density Lipoproteins as Magnetic Resonance Imaging Contrast Agents
Karen C. Briley-Saebo et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress
Maria D. Ganfornina et al.
AGING CELL (2008)
Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice
Michael Altenburg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis
Michael P. Caulfield et al.
CLINICAL CHEMISTRY (2008)
Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis
Wei Chen et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2008)
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease
Suzanne E. Wahrle et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform
David P. Cormode et al.
NANO LETTERS (2008)
LDL receptor-related protein 1: Unique tissue-specific functions revealed by selective gene knockout studies
Anna P. Lillis et al.
PHYSIOLOGICAL REVIEWS (2008)
An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection
David P. Cormode et al.
SMALL (2008)
ApoE ε2/ε3/ε4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome
O. Olivieri et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2007)
A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation
Peter A. C. McPherson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-β peptide generation
Woojin Scott Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression
Masachika Fujiyoshi et al.
JOURNAL OF NEUROCHEMISTRY (2007)
High density lipoprotein subfractions: isolation, composition, and their duplicitous role in oxidation
Peter A. C. McPherson et al.
JOURNAL OF LIPID RESEARCH (2007)
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
Tomas Vaisar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging
Juan C. Frias et al.
NANO LETTERS (2006)
Apolipoprotein E structure: insights into function
Danny M. Hatters et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1
Clara Cavelier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Intestinal ABCA1 directly contributes to HDL biogenesis in vivo
LR Brunham et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Signaling mechanisms regulating endothelial permeability
D Mehta et al.
PHYSIOLOGICAL REVIEWS (2006)
The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease
V Hirsch-Reinshagen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice
R Koldamova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease
SE Wahrle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex
PP Desai et al.
NEUROBIOLOGY OF DISEASE (2005)
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I
JM Timmins et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
CSF iron, ferritin and transferrin levels in restless legs syndrome
S Mizuno et al.
JOURNAL OF SLEEP RESEARCH (2005)
Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
A Chait et al.
JOURNAL OF LIPID RESEARCH (2005)
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
SE Wahrle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structure of human apolipoprotein A-IV: A distinct domain architecture among exchangeable apolipoproteins with potential functional implications
K Pearson et al.
BIOCHEMISTRY (2004)
Recombinant HDL-like nanoparticles: A specific contrast agent for MRI of atherosclerotic plaques
JC Frias et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus
R Memisogullari et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2004)
Uptake and transport of high-density lipoprotein (HDL) and HDL-associated α-tocopherol by an in vitro blood-brain barrier model
Z Balazs et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Altered apolipoprotein D expression in the brain of patients with Alzheimer disease
B Belloir et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Apolipoprotein specificity for lipid efflux by the human ABCAI transporter
AT Remaley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)